{"id":"ad-227b","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Dizziness"}]},"_chembl":{"chemblId":"CHEMBL5904289","moleculeType":null,"molecularWeight":"574.40"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By binding to the 5-HT2A receptor, AD-227B is believed to modulate the activity of this receptor, which is involved in various physiological processes including mood regulation and cognitive function.","oneSentence":"AD-227B is a small molecule that targets the serotonin receptor 5-HT2A.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:59:25.099Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment-resistant depression"}]},"trialDetails":[{"nctId":"NCT06884085","phase":"PHASE1","title":"A Study to Compare to PK Characteristics and Safety Profiles Between AD-227 and Co-administration of AD-227A and AD-227B","status":"COMPLETED","sponsor":"Addpharma Inc.","startDate":"2025-07-12","conditions":"Primary Hypertension","enrollment":70},{"nctId":"NCT06441630","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Co-administration of AD-227A and AD-227B","status":"RECRUITING","sponsor":"Addpharma Inc.","startDate":"2024-07-31","conditions":"Essential Hypertension","enrollment":251}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"AD-227B","genericName":"AD-227B","companyName":"Addpharma Inc.","companyId":"addpharma-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"AD-227B is a small molecule that targets the serotonin receptor 5-HT2A. Used for Treatment-resistant depression.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}